new post
StocksRunner logo
mail
search
 
menu
 
Haemonetics Corporat
$66.75
+31.50%
 
  Create Alerts  
  
  Overview  
  
  Comments  
  
  Insights  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Earnings  
  
  Headlines  
 

HAE Stock Analysis & IQ Rating | Haemonetics Corporat

 
 
 

HAE

 

Haemonetics Corporat

$66.75

 
+$15.99 | +31.50%
 
  Create Alerts  
  
  Overview  
  
  Comments  
  
  Insights  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Earnings  
  
  Headlines  
 
 
52W High
$ 94.99
 
 
MKT CAP
$ 3.20B
 
52W Low
$ 47.32
 
 
VOL
$ 3.07M
 
P/E Ratio
20.42
 
 
AVG VOL
$ 680.94K
 
RSI
79.92
 
 
TREND
Sideways
 
 
 

HAE Stock IQ

 
lock  Login to see Haemonetics Corporat (HAE) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
 
 

HAE Target Price

 
 
 
Not Enough Information
 
 
 

Risk Analysis

 

HAE Risk Analysis

 Investors losing their confidence

 
 

Chart

 
 

$50.24   (+32.86%)

$53.88   (+23.89%)

$76.87   (-13.17%)

$84.83   (-21.31%)

 
 
1year
6month
3month
1month
 

HAE Risk Level

 

HAE has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk

 
 
 
HAE Risk Level
Low
LOW
HIGH
 

HAE Analysts Opinion

 

HAE overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

 
 

Earnings

×
 

Earnings

 
 
 

Rating

×
 

Rating

 
 

Momentum

×
 

Momentum

 

HAE Momentum Analysis

 Price value has negative momentum

 

Activity

×
 

Activity

 

HAE Activity Sentiment

 Investors losing their confidence

 

Future

×
 

Future

 
 
 

HAE Analysts Opinion

HAE Analysts opinion is negative and it remained unchanged from the past 3 months

 

HAE Street Consensus

 

Analysts perspectives on the stock desirability, trend direction, and growth potential.

 
100%
Buy
Opinion
Trend
Score
Potential
Score
 
Consensus Rating
 
100%
100%
100%
 

HAE Street Opinion 

HAE Street view is extremely bullish and have negative views on the near-term outlook

 

HAE Performance Sentiment

 
Sentiments overview associated with HAE events and the stock performance.
 
100%
0%
Positive
Negative
5 out of 5
events present
0 out of 5
events present
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 

HAE Earnings

 

The TTM reflects 12-month period, providing review of HAE financial performance.

 
Millions of Dollars
TTM
2025
2024
CAGR
 
 
Total Revenue
1,346
1,361
1,309
+1.40%
 
 
Cost of Revenue
580
612
618
-3.12%
 
 
Gross Profit
766
749
692
+5.21%
 
 
Operating Exp
551
548
518
+3.14%
 
 
Operating Inc
215
201
173
+11.48%
 
 
Net Interest Inc
-25
-10
-13
-
 
 
Interest Exp
-
10
13
-
 
 
Other Inc Exp
-
21
-8
-
 
 
EPS Growth
3.29
3.33
2.32
+19.08%
 
 

HAE Financial Health

 

The company financial health has moderately improved over the past year

 

Financial Score

 
3.65
 
Next Earnings Date: Nov 6, 2025
 
 
HAE Latest Analysis +
 
 
FAQ About HAE Stock Insights
 

What is HAE current stock price?

What are HAE stock strengths?

What risks are associated with HAE stock?

When is HAE next earnings report?

What is HAE market cap and volume?

What is HAE's current Stock IQ?

Should I buy HAE stock right now?

Is HAE a Strong Buy right now?

What does a 'Strong Buy' rating mean for HAE?

What does a 'Strong Sell' rating mean for HAE?

What factors influence HAE's Stock IQ?

 
 
StocksRunner

Explore our HAE Stock insights

  • In-Depth Market Analysis and Trends
  • Expert Insights on Market Dynamics
  • Tailored HAE Stock Strategies
  • Effective Risk Management
 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss
 

Receive our HAE Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

 
Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

 
Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

 
Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

 
About StocksRunner

Log In

Sign Up

Plans & Pricing

Contact Us

Terms of use

Privacy Policy

 
 
StocksRunner
 
 
StocksRunner Overview
 
StocksRunner Trending
 
StocksRunner Screener
 
StocksRunner Insights
 
StocksRunner Top Rated
 
StocksRunner Momentum
 
StocksRunner Earnings
 
StocksRunner Leaders
mail
 
 

HAE

 

Haemonetics Corporat

 
 

Current Price

 

$66.75

 
+$15.99 | +31.50%
 
 
52W High
$ 94.99
 
 
MKT CAP
$ 3.20B
 
52W Low
$ 47.32
 
 
VOL
$ 3.07M
 
P/E Ratio
20.42
 
 
AVG VOL
$ 680.94K
 
RSI
79.92
 
 
TREND
Sideways
 
 
 
  Create Alerts  
  
  Overview  
  
  Comments  
  
  Insights  
  
   Risks   
  
  Rating  
  
  Chart  
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Earnings  
 
 
 
 

Target Price

 
 
 
 
Not Enough Information
 
 
 
 

Stock Insights

 
 
 
 

Risk Analysis

 

HAE Risk Analysis

 Investors losing their confidence

 
 
 
 
user
 
 
 
 
 

HAE Stock IQ

 
lock  Login to unlock Haemonetics Corporat (HAE) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
 

Chart

 
 

$50.24   (+32.86%)

$53.88   (+23.89%)

$76.87   (-13.17%)

$84.83   (-21.31%)

 
 
1year
6month
3month
1month
 

HAE Analysts Opinion

 

HAE Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

 
 

Earnings

×
 

Earnings

 
 
 

Rating

×
 

Rating

 
 

Momentum

×
 

Momentum

 

HAE Momentum Sentiment

 Price value has negative momentum

 

Activity

×
 

Activity

 

HAE Activity Sentiment

 Investors losing their confidence

 

Future

×
 

Future

 
 
 

HAE Analysts Opinion

HAE Analysts opinion is negative and it remained unchanged from the past 3 months

 

HAE Street Consensus

 

Analysts perspectives on the stock desirability, trend direction, and growth potential.

 
100%
Buy
Opinion
Trend
Score
Potential
Score
 
Consensus Rating
 
100%
100%
100%
 

HAE Street Opinion 

HAE Street view is extremely bullish and have negative views on the near-term outlook

 

HAE Risk Level

 

HAE has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk

 
 
 
HAE Risk Level
Low
LOW
HIGH
 
HAE Performance Sentiment
 
Sentiments overview associated with HAE events and the stock performance.
 
100%
0%
Positive
Negative
5 out of 5
events present
0 out of 5
events present
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 
 

HAE Earnings

 

The TTM data reflects the most recent 12-month period, providing overview of HAE financial performance.

 
Millions of Dollars
TTM
2025
2024
CAGR
 
 
Total Revenue
1,346
1,361
1,309
+1.40%
 
 
Cost of Revenue
580
612
618
-3.12%
 
 
Gross Profit
766
749
692
+5.21%
 
 
Operating Exp
551
548
518
+3.14%
 
 
Operating Inc
215
201
173
+11.48%
 
 
Net Interest Inc
-25
-10
-13
-
 
 
Interest Exp
-
10
13
-
 
 
Other Inc Exp
-
21
-8
-
 
 
EPS Growth
3.29
3.33
2.32
+19.08%
 
 

HAE Financial Health

 

The company financial health has moderately improved over the past year

 

Financial Score

 
3.65
 
Next Earnings Date: Nov 6, 2025
 
 
 
 
 

HAE Latest Analysis

 
 
 

Haemonetics Q2 Profit Climbs Lifts FY26 Adj. EPS View. Stock Up . (RTTNews) - Haemonetics Corp. (HAE) Thursday reported 14.3 percent increase in second quarter earnings to $38.68 million from $33.83 million last yer. On a per share basis earnings climbed 22.9 percent to $0.81 from $0.66 a year ago.

 

Today

$66.75 | +31.50%
 
Momentum

Haemonetics (HAE) Q2 Earnings and Revenues Surpass Estimates. Haemonetics (HAE) delivered earnings and revenue surprises of 13.39% and 5.22% respectively for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

 

Today

$66.75 | +31.50%
 
Earnings

Haemonetics Non-GAAP EPS of $1.27 beats by $0.16 revenue of $327M beats by $15.51M.

 

Today

$66.75 | +31.50%
 
Earnings

Haemonetics shares rise 3% as Q2 results top expectations guidance raised.

 

Today

$66.75 | +31.50%
 
Earnings

Should You Hold Haemonetics Corporation (HAE)?. Aristotle Capital Boston LLC an investment advisor released its Small/Mid Cap Equity Strategy third-quarter 2025 investor letter. A copy of the letter can be downloaded here. United States small/mid-cap equities reported solid results in the third quarter driven by a favorable macroeconomic backdrop. In the third quarter the strategy delivered a return of 2.57% net of [….]

 

Mon Nov 3, 2025

$50.27 | +0.52%
 
Earnings
 
 
 
 
 
StocksRunner

Discover HAE Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of HAE. We're here to help you make informed investment decisions today.

 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss

 

Receive our HAE Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

 
Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

HAE Stock trends

HAE Stock performance

HAE Stock analysis

HAE investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

 
 

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
StocksRunner logo
 

HAE Runner Alarm

Real-time signals powered by data
×

Price-Based

Triggers when the stock breaks through a known resistance level
 
Triggers when the stock drops below a key support level
 
Notifies if the stock moves up/down by a set percentage (e.g. ±5%)
 
Alerts when the stock hits a new high or low
 
Signals proximity to long-term highs or lows (e.g. within 5%)
 

Technical Indicator (Pro Plan)

Volume spikes 2x–3x above average. Indicates strong buying/selling pressure
 
Tracks large intraday swings, signaling potential opportunities or risk
 
Signals potential trend reversals or continuations
 
Long-term bullish/bearish trend signals from MA crossovers
 
RSI above 70 or below 30 to identify possible reversals
 
Signals momentum shifts
 

Fundamental (Master Plan)

Upcoming or just-released earnings reports
 
Alerts after results compared to expectations
 
Changes in rating or target price
 
New or changed dividends
 
Large trades by company insiders
 
M&A, lawsuits, product launches, etc
 
High volume/open interest in call/put contracts
 
Surge in mentions or sentiment shifts
 
 
 
×
 
0/666
joker
 
Post
 
✕
 
StocksRunner logo
 

Don't Be a Sheep, Be a StocksRunner

 

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

 
StocksRunner thumbnail
 
 

Sign up for free and

continue analysing HAE

 
Signup to Stocksrunner
 

Already a Member? Click here to Login

 

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

 
✕
 
StocksRunner logo
 

Don't Be a Sheep, Be a StocksRunner

 

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

 
StocksRunner thumbnail
 
 

Sign up for free and

continue analysing HAE

 
Signup to Stocksrunner
 

Already a Member? Click here to Login

 

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.